Category: Approval/Launch Region: Asia · India Company: Astrazeneca Pharma India Ltd

SEC seeks clinical trial data on Indians for approval of AstraZeneca breast cancer drug trastuzumab deruxtecan

SEC seeks clinical trial data on Indians for approval of AstraZeneca breast cancer drug trastuzumab deruxtecan
An expert committee, which advises the nation

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!